Short and long ‐term effectiveness and safety of vedolizumab in inflammatory bowel disease: results from the ENEIDA registry

Alimentary Pharmacology&Therapeutics,Volume 48, Issue 8, Page 839-851, October 2018.
Source: Alimentary Pharmacology and Therapeutics - Category: Drugs & Pharmacology Authors: Source Type: research